Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Global Therapeutic Vaccine Market Size, Share, Analysis and Forecast 2026

(PharmaNewsWire.Com, October 16, 2019 ) Market Overview:

A therapeutic vaccine are the biological preparations applied post infection confirmation, in order to induce antiviral immunity to alter the course of the disease. Therapeutic vaccine has expanded the horizon of chronic disease treatment. However, fast-track approvals by US FDA for therapeutic vaccine for various disease shall be essentially intensified. Due to increasing chronic infectious diseases, allergic conditions, auto immune disorders, cancer etc., and lack of vaccines approvals, is expected to create the negative shift towards the healthcare expenditure for low to emerging economic county population.



Market Dynamics:

Therapeutic Vaccines Market is driven by rising incidences of chronic infectious diseases, cancer, Alzheimer’s disease etc.



However huge capital expenditure in vaccine development is hampering the market growth. Merely 22% of the initiatives were forecasted in 1996 to successfully reach the market after 10 years of development.



Market Segmentation:

Based on type, the Therapeutic Vaccines Market is segmented into Tumor cell vaccine, Antigen vaccines, Dendritic Cell vaccine, DNA vaccine.

Rising incidences of cancer leading to rising demand for the development of tumor cell vaccines is one of the dominating factors, propelling the global therapeutic vaccines market.

On the basis of disease type, the therapeutic vaccines market is segmented into Autoimmune Disease Vaccine, Infectious Disease Vaccine, Neurological Disease Vaccines, Addiction Vaccine, and others.



On the basis of technology, the therapeutic vaccines market is segmented into Autologous Vaccines and Allogeneic Vaccines. Autologous vaccines are expected to boost the market over the period of forecast.



Geographical Analysis:

Geographically, the market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.



North America is dominating the Therapeutic Vaccines Market in 2018 and estimated to hold largest market size over the forecast period (2019-2026) owing to rising incidence of chronic infectious diseases, cancer, Alzheimer’s, and others.



Competitive Analysis:

Some of the major players in the Therapeutic Vaccines Market are GlaxoSmithKline, Merck & Co., Pfizer, Vaccinogen Inc. Sanofi Agenus Inc.



GlaxoSmithKline has an extensive portfolio and a pipeline of therapeutic vaccines. GSK1265744 (cabotegravir) for HIV (pre-exposure prophylaxis) is in Phase III which acts as a HIV integrase inhibitor. GSK137173A (Shingrix) for Herpes Zoster prophylaxis is a immune compromised vaccine in Phase III.



View full report: https://www.datamintelligence.com/research-report/therapeutic-vaccine-market



Download free sample: https://www.datamintelligence.com/download-sample/therapeutic-vaccine-market



About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.



For more information:

Sai Kiran

Sales Manager at Data M Intelligence

Email: pr@datamintelligence.com

Tel: +1 877 441 4866

Website: www.datamintelligence.com

DataM Intelligence

Sai Kiran

+1 877 441 4866

pr@datamintelligence.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC